(CEVA) CEVA - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1572101053

CEVA: Signal Processors, Modem Platforms, Wireless Platforms, AI Accelerators, Audio DSPs

CEVA, Inc. provides silicon and software IP solutions to semiconductor and original equipment manufacturer (OEM) companies worldwide. Its 5G mobile and infrastructure products include Ceva-XC vector digital signal processors (DSPs) for 5G handsets, 5G RAN, and general-purpose baseband processing; PentaG-RAN, an open ran platform for base station and radio; and PentaG2 - 5G NR modem platform for UE, as well as for non-handset 5G vertical markets, such as fixed wireless access, industry 4.0, robotics, and AR/VR devices. The company's wireless IoT products comprise RivieraWaves' Bluetooth 5dual mode and low energy platforms, RivieraWaves' Wi-Fi platforms, ultra-wide band platforms, and Cellular IoT and RedCap platforms, as well as sense and inference processors and platforms consist of NeuPro-M neural processing unit (NPU) family; SensPro2 sensor hub AI platforms addressing imaging, vision, powertrain, and applications, including DSP processors, AI accelerators, and a software portfolio; and Ceva-BX1 and Ceva-BX2 audio AI DSPs. Its sensing and audio software comprise RealSpace spatial audio software package; WhisPro speech recognition; ClearVox, a voice front-end software package for voice-enabled devices; and CDNN, a neural network graph compiler that enables AI developers to automatically compile, optimize, and run pre-trained networks onto embedded devices. The company's application software IP are licensed primarily to OEMs who embed it in their system on chip designs. It delivers AI DSPs and NPUs in the form of a hardware description language definition; and offers development platforms, software development kits, and software debug tools, which facilitate system design, debug, and software development. The company licenses its technology through a direct sales force. CEVA, Inc. was formerly known as ParthusCeva, Inc. and changed its name to CEVA, Inc. in December 2003. The company was incorporated in 1999 and is headquartered in Rockville, Maryland. Web URL: https://www.ceva-ip.com

Additional Sources for CEVA Stock

CEVA Stock Overview

Market Cap in USD 808m
Sector Technology
Industry Semiconductors
GiC Sub-Industry Semiconductors
IPO / Inception 2000-05-19

CEVA Stock Ratings

Growth 5y -4.91%
Fundamental -6.66%
Dividend -
Rel. Strength Industry 24.1
Analysts 4.33/5
Fair Price Momentum 32.94 USD
Fair Price DCF -

CEVA Dividends

No Dividends Paid

CEVA Growth Ratios

Growth Correlation 3m 89.8%
Growth Correlation 12m 70.8%
Growth Correlation 5y -70.2%
CAGR 5y 2.88%
CAGR/Mean DD 5y 0.06
Sharpe Ratio 12m 1.08
Alpha 32.47
Beta 1.27
Volatility 42.47%
Current Volume 292.4k
Average Volume 20d 296.8k
What is the price of CEVA stocks?
As of January 30, 2025, the stock is trading at USD 31.87 with a total of 292,388 shares traded.
Over the past week, the price has changed by -6.26%, over one month by -0.53%, over three months by +27.28% and over the past year by +56.76%.
Is CEVA a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, CEVA is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -6.66 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CEVA as of January 2025 is 32.94. This means that CEVA is currently overvalued and has a potential downside of 3.36%.
Is CEVA a buy, sell or hold?
CEVA has received a consensus analysts rating of 4.33. Therefor, it is recommend to buy CEVA.
  • Strong Buy: 3
  • Buy: 2
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CEVA stock price target?
According to ValueRays Forecast Model, CEVA CEVA will be worth about 37 in January 2026. The stock is currently trading at 31.87. This means that the stock has a potential upside of +15.97%.
Issuer Forecast Upside
Wallstreet Target Price 33.5 5.1%
Analysts Target Price 33.5 5.1%
ValueRay Target Price 37 16%